Oncologists using or considering AI tools tend to agree among themselves on three points of ethics—and to recognize the same number of ways AI could help advance the state of patient care. 

Buzzworthy developments of the past few days.

Is U.S. healthcare capable of achieving its own quadruple aim? Or is that ideal destined to remain a perpetual pursuit, always chased but never really caught?

The ongoing rise of private equity continues to be one of the biggest topics in modern healthcare. 

Tracking private equity acquisitions can be challenging, but that didn't stop researchers from exploring the last decade of activity in cardiology. "It will be critical to monitor the effects on procedural utilization, quality and outcomes for patients with CVD,” the group wrote. 

Impella heart pumps may not provide as much value when treating high-risk patients as early data suggested.

Buzzworthy developments of the past few days.

The U.S. is far from alone in the world in its wranglings across public and private sectors to adopt propitious healthcare AI innovations quickly yet safely.